BioStem Technologies, Inc.
BSEM
$3.71
-$0.25-6.22%
OTC PK
| 03/31/2026 | 09/30/2025 | 06/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -325.68% | -88.84% | -108.98% | -108.98% | 19.96% |
| Total Depreciation and Amortization | 658.39% | 83.23% | 0.89% | 0.89% | 50.48% |
| Total Amortization of Deferred Charges | -- | -100.00% | -81.97% | -81.97% | 19.38% |
| Total Other Non-Cash Items | -20.79% | 42.68% | 76.19% | 76.19% | -40.30% |
| Change in Net Operating Assets | 406.68% | -416.07% | 328.59% | 328.59% | 68.55% |
| Cash from Operations | -120.26% | -125.31% | -14.57% | -14.57% | 635.10% |
| Capital Expenditure | 98.91% | -1,919.72% | -103.68% | -103.68% | -1,228.23% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 200.00% | -- | -- | -- |
| Cash from Investing | -9,019.73% | 14.76% | -103.68% | -103.68% | -1,228.23% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -42.99% | -260.63% | -260.63% | 73.76% |
| Issuance of Common Stock | -- | -85.00% | -- | -- | -86.68% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -2,655.10% | -260.63% | -260.63% | 50.36% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -512.57% | -145.84% | -29.66% | -29.66% | 851.14% |